These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2463024)

  • 1. Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.
    Ito K; Hayashi K; Nakashima T; Murakami T
    Br J Pharmacol; 1988 Aug; 94(4):1167-74. PubMed ID: 2463024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
    Ito K; Nakashima T; Murakami K; Murakami T
    Br J Pharmacol; 1988 Aug; 94(4):1175-83. PubMed ID: 3145089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
    Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
    Molteni A; Ward WF; Ts'ao CH; Solliday NH
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):483-93. PubMed ID: 3016747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cancer metastasis after monocrotaline-induced lung injury.
    Vincic L; Orr FW; Warner DJ; Suyama KL; Kay JM
    Toxicol Appl Pharmacol; 1989 Sep; 100(2):259-70. PubMed ID: 2506673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
    Molteni A; Ward WF; Ts'ao CH; Hinz JM
    Biochem Pharmacol; 1989 Aug; 38(15):2411-9. PubMed ID: 2547380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril potentiates depressor responses to arachidonic acid in the rat.
    Hui SC; Boura AL
    Clin Exp Pharmacol Physiol; 1982; 9(6):679-83. PubMed ID: 6819911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):421-31. PubMed ID: 1830177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither anticoagulant nor nonanticoagulant heparin affects monocrotaline lung injury.
    Fasules JW; Stenmark KR; Henson PM; Voelkel NF; Reeves JT
    J Appl Physiol (1985); 1987 Feb; 62(2):816-20. PubMed ID: 3104299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and peripheral effects of bradykinin and prostaglandin E2 on blood pressure in conscious rats.
    Kondo K; Okuno T; Konishi K; Saruta T; Kato E
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):111-5. PubMed ID: 388242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin.
    Heller LJ; Mohrman DE
    Life Sci; 1998; 62(9):PL121-5. PubMed ID: 9496705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
    Gillespie MN; Olson JW; Reinsel CN; O'Connor WN; Altiere RJ
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
    Hui SC; Dai S; Ogle CW
    Clin Exp Pharmacol Physiol; 1984; 11(6):621-5. PubMed ID: 6100239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617.
    Molteni A; Ward WF; Ts'ao C; Solliday NH
    Arch Int Pharmacodyn Ther; 1988; 291():21-40. PubMed ID: 3129998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.